Cargando…
Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation
INTRODUCTION: The application of botulinum toxin type A (BoNTA) is accelerating, and this includes the uncontrolled cosmetic use of the BoNTA. Diffusion of BoNTA can disturb neuromuscular transmission in several surrounding and distant muscles and result in clinical manifestations similar to myasthe...
Autores principales: | Punga, Anna Rostedt, Liik, Maarika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044641/ https://www.ncbi.nlm.nih.gov/pubmed/32140629 http://dx.doi.org/10.1016/j.cnp.2020.01.002 |
Ejemplares similares
-
Keeping up appearances: Don’t frown upon the effects of botulinum toxin injections in facial muscles
por: Punga, Anna Rostedt, et al.
Publicado: (2023) -
Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries
por: Sabre, Liis, et al.
Publicado: (2017) -
Epidemiology of Myasthenia Gravis in Sweden 2006–2016
por: Westerberg, Elisabet, et al.
Publicado: (2020) -
Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine
por: Sabre, Liis, et al.
Publicado: (2020) -
Editorial: Advances in Autoimmune Myasthenia Gravis
por: Punga, Anna Rostedt, et al.
Publicado: (2020)